Prognostic factors in acute myeloid leukaemia
- 31 March 2001
- journal article
- review article
- Published by Elsevier in Best Practice & Research Clinical Haematology
- Vol. 14 (1) , 65-75
- https://doi.org/10.1053/beha.2000.0116
Abstract
No abstract availableKeywords
This publication has 45 references indexed in Scilit:
- Chemotherapy Compared with Autologous or Allogeneic Bone Marrow Transplantation in the Management of Acute Myeloid Leukemia in First RemissionNew England Journal of Medicine, 1998
- Mitoxantrone versus daunorubicin in induction-consolidation chemotherapy--the value of low-dose cytarabine for maintenance of remission, and an assessment of prognostic factors in acute myeloid leukemia in the elderly: final report. European Organization for the Research and Treatment of Cancer and the Dutch-Belgian Hemato-Oncology Cooperative Hovon Group.Journal of Clinical Oncology, 1998
- Randomised comparison of addition of autologous bone-marrow transplantation to intensive chemotherapy for acute myeloid leukaemia in first remission: results of MRC AML 10 trialThe Lancet, 1998
- Autologous or Allogeneic Bone Marrow Transplantation Compared with Intensive Chemotherapy in Acute Myelogenous LeukemiaNew England Journal of Medicine, 1995
- Intensive Postremission Chemotherapy in Adults with Acute Myeloid LeukemiaNew England Journal of Medicine, 1994
- A phase III trial comparing idarubicin and daunorubicin in combination with cytarabine in acute myelogenous leukemia: a Southeastern Cancer Study Group Study.Journal of Clinical Oncology, 1992
- Cytarabine plus idarubicin or daunorubicin as induction and consolidation therapy for previously untreated adult patients with acute myeloid leukemiaBlood, 1992
- Clonogenic cells in acute myeloblastic leukemiaBlood, 1986
- Further results in understanding the subpopulation structure of AML: clonogenic cells and their progeny identified by differentiation markersBlood, 1985
- Acute nonlymphocytic leukemia: heterogeneity of stem cell originBlood, 1981